Study Phase 4

An Open Label Study to Evaluate Cycle Control with Ortho Tri-Cyclen Lo (norgestimate/ethinyl estradiol) and Yaz (drospirenone/ethinyl estradiol) in Healthy Sexually Active Females

Trial Information

Generic NameNorgestimateProduct NameMONONESSA ® ORTHO-CYCLEN ® ORTHO TRI-CYCLEN ® TRINESSA ®Therapeutic AreaUrinary Tract, Sexual Organs, and Pregnancy ConditionsEnrollment355% FemaleN/A% WhiteN/A
Product ClassOB/GYNSponsor Protocol NumberNRGMONCON4002Data PartnerJohnson & JohnsonCondition StudiedContraceptionMean/Median Age (Years)N/A

Supporting Documentation

  • Protocol with Amendments Available
  • Statistical Analysis Plan Available
  • Clinical Study Report Available
Additional Information

Please note: individual participant-level data are not available for this trial. Only the protocol, statistical analysis plan, and full clinical study report are available.


Clinical study data provided through this site do not replace the official labeling of a given drug product, which presents benefits and risks of the product for approved use(s). Before prescribing any product, health care professionals should consult the current prescribing information approved in their country. Patients seeking information may consult with their health care professional about the product, for which health authority approved written patient information may be available.